Geode Capital Management LLC Boosts Holdings in The Clorox Company $CLX

Geode Capital Management LLC grew its position in The Clorox Company (NYSE:CLXFree Report) by 0.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,172,233 shares of the company’s stock after buying an additional 10,060 shares during the period. Geode Capital Management LLC’s holdings in Clorox were worth $318,613,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. State Street Corp grew its stake in shares of Clorox by 3.5% in the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after buying an additional 282,794 shares during the period. Invesco Ltd. grew its stake in shares of Clorox by 23.1% in the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after buying an additional 750,415 shares during the period. Van ECK Associates Corp grew its stake in shares of Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after buying an additional 1,312,471 shares during the period. Two Sigma Investments LP grew its stake in shares of Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the period. Finally, Northern Trust Corp grew its stake in shares of Clorox by 4.8% in the 3rd quarter. Northern Trust Corp now owns 1,539,006 shares of the company’s stock valued at $189,759,000 after buying an additional 70,783 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.63% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CLX has been the subject of several analyst reports. Evercore reissued an “underperform” rating and issued a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. Barclays lowered their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. TD Cowen increased their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Jefferies Financial Group lowered their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Finally, Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $103.40.

View Our Latest Stock Analysis on Clorox

Clorox Price Performance

Clorox stock opened at $89.10 on Tuesday. The firm has a market cap of $10.77 billion, a PE ratio of 14.46, a price-to-earnings-growth ratio of 0.47 and a beta of 0.59. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company’s 50 day moving average is $98.11 and its two-hundred day moving average is $105.71.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.